AR028204A1 - Composiciones farmaceuticas electrohiladas - Google Patents

Composiciones farmaceuticas electrohiladas

Info

Publication number
AR028204A1
AR028204A1 ARP010100354A ARP010100354A AR028204A1 AR 028204 A1 AR028204 A1 AR 028204A1 AR P010100354 A ARP010100354 A AR P010100354A AR P010100354 A ARP010100354 A AR P010100354A AR 028204 A1 AR028204 A1 AR 028204A1
Authority
AR
Argentina
Prior art keywords
electro
threaded
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ARP010100354A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR028204A1 publication Critical patent/AR028204A1/es

Links

Classifications

    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/0023—Electro-spinning characterised by the initial state of the material the material being a polymer melt
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Textile Engineering (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Mechanical Engineering (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Virology (AREA)
ARP010100354A 2000-01-28 2001-01-26 Composiciones farmaceuticas electrohiladas AR028204A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17868200P 2000-01-28 2000-01-28

Publications (1)

Publication Number Publication Date
AR028204A1 true AR028204A1 (es) 2003-04-30

Family

ID=22653497

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100354A AR028204A1 (es) 2000-01-28 2001-01-26 Composiciones farmaceuticas electrohiladas

Country Status (18)

Country Link
EP (1) EP1251829A4 (fr)
JP (1) JP2003521493A (fr)
KR (1) KR100806412B1 (fr)
CN (1) CN1223340C (fr)
AR (1) AR028204A1 (fr)
AU (1) AU772830B2 (fr)
BR (1) BR0107869A (fr)
CA (1) CA2396640A1 (fr)
HU (1) HUP0301130A3 (fr)
IL (1) IL150642A0 (fr)
MX (1) MXPA02007298A (fr)
MY (1) MY129356A (fr)
NO (1) NO20023338L (fr)
NZ (1) NZ519992A (fr)
PL (1) PL356924A1 (fr)
TW (1) TWI289061B (fr)
WO (1) WO2001054667A1 (fr)
ZA (1) ZA200205989B (fr)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
WO2002032397A2 (fr) * 2000-10-18 2002-04-25 Virginia Commonwealth University Intellectual Property Foundation Mise en oeuvre d'un traitement electrique pour l'administration de medicaments et l'encapsulation de cellules
ES2312495T3 (es) * 2000-11-17 2009-03-01 Virginia Commonwealth University Intellectual Property Foundation Colageno electroprocesado.
JP2010163435A (ja) * 2000-11-17 2010-07-29 Virginia Commonwealth Univ Intellectual Property Foundation 電気処理されたコラーゲン
WO2002074189A2 (fr) * 2001-03-20 2002-09-26 Nicast Ltd. Procede et appareil destines a ameliorer les caracteristiques mecaniques de nontisses
US6685956B2 (en) * 2001-05-16 2004-02-03 The Research Foundation At State University Of New York Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
ES2305434T3 (es) 2002-02-01 2008-11-01 Pfizer Products Inc. Composiciones framaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
KR100549140B1 (ko) 2002-03-26 2006-02-03 이 아이 듀폰 디 네모아 앤드 캄파니 일렉트로-브로운 방사법에 의한 초극세 나노섬유 웹제조방법
US8367570B2 (en) 2002-04-04 2013-02-05 The University Of Akron Mechanically strong absorbent non-woven fibrous mats
AU2003228460A1 (en) 2002-04-04 2003-10-27 The University Of Akron Non-woven fiber assemblies
JP2005522594A (ja) * 2002-04-11 2005-07-28 セカント メディカル， インコーポレイテッド 非常に小さいペプチドの電気紡績を使用するカバープロセス
US20060083784A1 (en) * 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
TW200410714A (en) * 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
WO2004062697A2 (fr) 2003-01-07 2004-07-29 Tufts University Matières de fibroïne de soie et utilisation de celles-ci
WO2005011635A2 (fr) 2003-08-04 2005-02-10 Pfizer Products Inc. Compositions pharmaceutiques a base d'adsorbats de medicaments amorphes et de produits aptes a former des microphases lipophiles
JP2007517016A (ja) 2003-12-31 2007-06-28 ファイザー・プロダクツ・インク 低溶解性薬剤及びポロキサマーの固体組成物
JP4526851B2 (ja) * 2004-03-31 2010-08-18 明彦 谷岡 多糖類のナノスケールの繊維および成形体
WO2006006746A1 (fr) * 2004-07-09 2006-01-19 Hak-Yong Kim Particules polymeres et procede de fabrication
CN100577720C (zh) * 2005-03-21 2010-01-06 中国科学院化学研究所 可生物降解及吸收的聚合物纳米纤维膜材料及制法和用途
JP2006299459A (ja) * 2005-04-20 2006-11-02 National Institute For Materials Science 生分解性高分子不織布チューブの製造方法
CN1300393C (zh) * 2005-07-01 2007-02-14 中国科学院长春应用化学研究所 超细纤维药物剂型的乳液电纺丝制备方法
JP5339328B2 (ja) * 2005-07-21 2013-11-13 独立行政法人物質・材料研究機構 薬物吸入デバイス
JP4787585B2 (ja) * 2005-09-29 2011-10-05 帝人株式会社 静電紡糸法による繊維構造体の製造方法
CN100556399C (zh) * 2005-12-23 2009-11-04 中国科学院广州化学研究所 一种肠靶向型药物控释纤维及其制备方法
US8367112B2 (en) * 2006-02-28 2013-02-05 Alkermes Pharma Ireland Limited Nanoparticulate carverdilol formulations
KR100824719B1 (ko) * 2006-09-04 2008-04-24 주식회사 아모메디 전분함유 나노섬유 부직포로 이루어진 생분해성 식품포장재 및 그 제조방법
CA2719637C (fr) * 2008-03-27 2014-10-28 Agigma, Inc. Procedes et compositions pour la delivrance d'agents
ES2893310T3 (es) 2008-04-16 2022-02-08 Procter & Gamble Premezcla para un artículo para la higiene personal no espumante, teniendo el artículo la forma de una espuma sólida
JP2011530661A (ja) * 2008-08-08 2011-12-22 ビーエーエスエフ ソシエタス・ヨーロピア 活性成分の制御放出を伴う有効成分含有繊維表面構造体、その使用、およびその生産のための方法
EP2684562A1 (fr) 2008-08-08 2014-01-15 Basf Se Structure fibreuse plate contenant des principes actifs à base de biopolymères, ses applications et son procédé de fabrication
CN101721751B (zh) * 2008-10-10 2013-01-02 张阳德 负载了缓释细胞生长因子的具有内核的中空二氧化硅球的人体组织工程支架及其制法和用途
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
KR101065255B1 (ko) * 2009-02-13 2011-09-16 김근형 생분해성 폴리머의 전기방사를 이용한 신규 약물 전달 시스템
CN101559242B (zh) * 2009-05-22 2015-07-29 广州迈普再生医学科技有限公司 一种可同时作为药物缓释体系的纳米人工硬脑膜及其制备方法
WO2011029777A1 (fr) 2009-09-11 2011-03-17 Basf Se Procédés de production de fibres polymères enduites
US9295859B2 (en) 2009-12-08 2016-03-29 The Procter & Gamble Company Porous, dissolvable solid substrate and surface resident coating comprising matrix microspheres
WO2011103152A1 (fr) 2010-02-16 2011-08-25 The Procter & Gamble Company Substrat solide soluble poreux et revêtement de surface comprenant du pyrithione de zinc
CN101816627B (zh) * 2010-04-16 2012-03-07 浙江大学 一种协同治疗型多物质缓释滴眼剂及制备方法
RU2555042C2 (ru) 2010-07-02 2015-07-10 Дзе Проктер Энд Гэмбл Компани Способ доставки активнодействующего вещества
MX2012015169A (es) * 2010-07-02 2013-05-09 Procter & Gamble Filamentos que comprenden un agente activo sin perfume, tramas de tela no tejida y métodos para elaborarlos.
RU2535040C2 (ru) * 2010-07-02 2014-12-10 Дзе Проктер Энд Гэмбл Компани Способы доставки медицинского активного агента путем введения индивидуальных медицинских изделий, содержащих филамент
EP2588288B1 (fr) 2010-07-02 2015-10-28 The Procter and Gamble Company Procédé de fabrication de films à partir de bandes non tissées
JP5792297B2 (ja) 2010-07-02 2015-10-07 ザ プロクター アンド ギャンブルカンパニー 洗剤製品
MX2012015174A (es) 2010-07-02 2013-05-09 Procter & Gamble Filamentos que comprenden un agente activo, tramas de tela no tejida y métodos para elaborarlos.
MX360481B (es) * 2010-07-02 2018-11-05 Procter & Gamble Articulo con estructura soluble de trama fibrosa que comprende agentes activos.
RU2012154298A (ru) * 2010-07-02 2014-08-10 Дзе Проктер Энд Гэмбл Компани Филаменты, содержащие пригодные для приема внутрь активные агенты, нетканые полотна и способы их изготовления
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
CN101915797B (zh) * 2010-07-27 2011-09-28 北京师范大学 一种静电纺丝固定化漆酶电极的制备方法
US9808418B2 (en) 2010-11-26 2017-11-07 University Of The Witwatersrand, Johannesburg Pharmaceutical dosage form
WO2012084441A1 (fr) 2010-12-22 2012-06-28 Unilever Nv Compositions sous la forme de fibres
WO2012084427A1 (fr) 2010-12-22 2012-06-28 Unilever Nv Compositions comprenant une phase liquide non aqueuse structurée
CZ201124A3 (cs) 2011-01-17 2012-06-13 Elmarco S.R.O. Nosic pro oromukosální, zejména pro sublingvální aplikaci fyziologicky aktivních látek
CN102251317B (zh) * 2011-05-18 2013-01-16 东华大学 一种药物释放可控的电纺纤维的制备方法
WO2013124869A2 (fr) * 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University Technique, méthode, manière, procédé et système associés à des plaquettes polymères fibreuses biodégradables pour l'administration locale d'agents thérapeutiques en combinaisons
CN102631715A (zh) * 2012-05-04 2012-08-15 江南大学 一种抗凝血纳米纤维膜的制备方法
CN102670483B (zh) * 2012-05-09 2014-04-02 上海交通大学 一种用于高血脂症治疗的静电纺丝纤维膜制剂及其制备方法
CN102697727B (zh) * 2012-06-12 2014-01-08 东华大学 一种利用静电纺丝技术制备自组装酮洛芬脂质体的方法
KR101454360B1 (ko) 2012-08-31 2014-10-24 서울대학교산학협력단 파에도닥틸룸 트리코르누툼 추출물을 함유하는 젤라틴 나노섬유 지지체 및 이를 이용한 창상피복재
CN104884037B (zh) 2012-10-12 2018-02-16 宝洁公司 可溶性制品形式的个人护理组合物
WO2014131376A1 (fr) * 2013-02-26 2014-09-04 Elmarco S.R.O. Nanofibres électrofilées comprenant des agents pharmaceutiquement actifs
WO2014142675A1 (fr) 2013-03-12 2014-09-18 Active Fibres Limited Compositions de nanofibre et bioactives et procédés associés
EP2813212A1 (fr) 2013-06-10 2014-12-17 Zentiva, a.s. Formulation médicinale, employant l'API en nanofibres
US10202636B2 (en) 2013-12-24 2019-02-12 General Electric Company Electrospun fibers for protein stabilization and storage
CN106413683A (zh) 2014-04-22 2017-02-15 宝洁公司 可溶性固体结构体形式的组合物
US9937111B2 (en) 2014-05-05 2018-04-10 The Procter & Gamble Company Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating
US9877899B2 (en) 2014-05-05 2018-01-30 The Procter & Gamble Company Consumer product comprising a fibrous web structure with a silicone conditioning agent coating
US9861559B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating
US9827173B2 (en) 2014-05-05 2017-11-28 The Procter & Gamble Company Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom
US9861558B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Methods of forming an aqueous treatment liquor by dissolving a porous solid with a benefit agent coating
US9867762B2 (en) 2014-05-05 2018-01-16 The Procter & Gamble Company Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating
RU2019121301A (ru) * 2014-06-10 2019-08-20 Афикс Терапьютикс А/С Композиции, включающие электрогидродинамически полученные волокна, для нанесения заданных доз активного вещества на кожу или слизистую оболочку
CN105362269A (zh) * 2014-09-01 2016-03-02 天津药物研究院 一种含蔗糖的罗氟司特片及其制备方法
WO2016159240A1 (fr) * 2015-03-31 2016-10-06 Ｏｒｔｈｏｒｅｂｉｒｔｈ株式会社 Procédé de fabrication de matériau de fibre biodégradable contenant un médicament par filage électrostatique
WO2017007842A1 (fr) * 2015-07-07 2017-01-12 Singapore Health Services Pte Ltd. Produit polymère et son procédé de préparation
CN105327357B (zh) * 2015-10-14 2019-01-11 北京科技大学 一种邻苯二酚修饰的透明质酸的载药系统及其制备方法
SG10201913222XA (en) * 2015-11-19 2020-03-30 Afyx Therapeutics As A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
JP7126260B2 (ja) * 2016-01-27 2022-08-26 インスター テクノロジーズ アクチオヴァ スプルチュノスト 治療処置用の口腔粘膜ナノファイバ担体
CN105727358B (zh) * 2016-02-23 2019-01-22 广西易得佳医疗器械有限公司 载药生物高分子复合纳米纤维膜及其制备方法
CN105663025A (zh) * 2016-02-29 2016-06-15 浙江工业大学 一种含药微丝及其制备方法
BR112019014236A2 (pt) 2017-01-23 2020-03-17 Afyx Therapeutics A/S Método para a fabricação de um produto de duas camadas à base de fibras eletrofiadas
RU2019126497A (ru) 2017-01-23 2021-02-24 Афикс Терапьютикс А/С Способ получения электроспряденных волокон с высоким содержанием биоадгезивнго вещества
WO2018140675A1 (fr) 2017-01-27 2018-08-02 The Procter & Gamble Company Compositions sous forme de structures solides solubles comprenant des particules agglomérées effervescentes
EP4245296A3 (fr) 2017-01-27 2023-12-06 The Procter & Gamble Company Compositions sous la forme de structures solides et solubles
WO2018213003A1 (fr) 2017-05-16 2018-11-22 The Procter & Gamble Company Compositions de conditionnement pour soins capillaires sous la forme de structures solides solubles
CN107447366A (zh) * 2017-08-03 2017-12-08 东华大学 一种pH敏感载药缓释纳米纤维膜及其制备方法和应用
WO2019147532A1 (fr) 2018-01-26 2019-08-01 The Procter & Gamble Company Articles en dose unitaire soluble dans l'eau comprenant un parfum
WO2019147523A1 (fr) 2018-01-26 2019-08-01 The Procter & Gamble Company Articles solubles dans l'eau et procédés connexes
KR20200085891A (ko) 2018-01-26 2020-07-15 더 프록터 앤드 갬블 캄파니 향료를 포함하는 수용성 단위 용량 물품
CN111556891B (zh) 2018-01-26 2021-11-05 宝洁公司 包含酶的水溶性单位剂量制品
WO2019168829A1 (fr) 2018-02-27 2019-09-06 The Procter & Gamble Company Produit de consommation comprenant un conditionnement plat contenant des articles de dose unitaire
JP7121944B2 (ja) * 2018-05-07 2022-08-19 国立大学法人信州大学 ナノ繊維及びその製造方法
JP1629688S (fr) 2018-07-16 2019-04-15
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
WO2020159860A1 (fr) 2019-01-28 2020-08-06 The Procter & Gamble Company Emballage recyclable, renouvelable ou biodégradable
EP3712237A1 (fr) 2019-03-19 2020-09-23 The Procter & Gamble Company Articles fibreux de dose unitaire soluble dans l'eau comprenant des structures fibreuses solubles dans l'eau
CA3134222C (fr) 2019-06-28 2024-01-16 The Procter & Gamble Company Articles fibreux solides solubles contenant des tensioactifs anioniques
JP7393441B2 (ja) 2019-07-03 2023-12-06 ザ プロクター アンド ギャンブル カンパニー カチオン性界面活性剤及び可溶性酸を含有する繊維構造体
USD939359S1 (en) 2019-10-01 2021-12-28 The Procter And Gamble Plaza Packaging for a single dose personal care product
JP7473636B2 (ja) 2019-10-14 2024-04-23 ザ プロクター アンド ギャンブル カンパニー 固体物品を収容する生分解性及び／又は家庭で堆肥化可能な小袋
CA3157576A1 (fr) 2019-11-20 2021-05-27 The Procter & Gamble Company Structure solide poreuse soluble
CN114929182B (zh) 2019-12-01 2024-05-28 宝洁公司 具有含有苯甲酸钠和二醇和/或甘油酯的防腐体系的毛发调理剂组合物
USD962050S1 (en) 2020-03-20 2022-08-30 The Procter And Gamble Company Primary package for a solid, single dose beauty care composition
USD941051S1 (en) 2020-03-20 2022-01-18 The Procter And Gamble Company Shower hanger
USD965440S1 (en) 2020-06-29 2022-10-04 The Procter And Gamble Company Package
CN115867357A (zh) 2020-07-31 2023-03-28 宝洁公司 用于毛发护理的含有球粒的水溶性纤维小袋
CN116018123A (zh) 2020-08-11 2023-04-25 宝洁公司 含有芸苔油醇缬氨酸酯乙磺酸盐的保湿毛发调理剂组合物
JP2023535385A (ja) 2020-08-11 2023-08-17 ザ プロクター アンド ギャンブル カンパニー ブラシシルバリネートエシレートを含有するクリーンリンスヘアコンディショナー組成物
US11633336B2 (en) 2020-08-11 2023-04-25 The Procter & Gamble Company Low viscosity hair conditioner compositions containing brassicyl valinate esylate
MX2023005792A (es) 2020-12-01 2023-05-29 Procter & Gamble Composiciones acuosas acondicionadoras de cabello que contienen activos anticaspa solubilizados.
CN113041230B (zh) * 2021-03-23 2022-06-24 浙江尖峰健康科技有限公司 一种软胶囊的囊皮及由其制备的软胶囊
KR102653460B1 (ko) * 2021-09-01 2024-03-29 한남대학교 산학협력단 콜라겐과 레시틴을 포함하는 분해도 조절이 가능한 스타치 나노섬유의 제조방법
WO2023145886A1 (fr) * 2022-01-31 2023-08-03 三菱ケミカル株式会社 Nanofibres
CN114808184A (zh) * 2022-03-11 2022-07-29 深圳市法鑫忠信新材料有限公司 一种长效驱蚊的静电纺丝纤维及其制备方法和应用
CN115887422B (zh) * 2022-12-31 2024-06-07 兰州交通大学 一种高乌甲素膝骨关节镇痛缓释贴及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1527592A (en) * 1974-08-05 1978-10-04 Ici Ltd Wound dressing
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US5567439A (en) 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
US6753454B1 (en) * 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor

Also Published As

Publication number Publication date
HUP0301130A3 (en) 2006-07-28
AU3113401A (en) 2001-08-07
NO20023338D0 (no) 2002-07-11
CA2396640A1 (fr) 2001-08-02
EP1251829A4 (fr) 2009-05-06
NO20023338L (no) 2002-09-03
KR20020082212A (ko) 2002-10-30
HUP0301130A2 (hu) 2003-09-29
MY129356A (en) 2007-03-30
CN1396823A (zh) 2003-02-12
MXPA02007298A (es) 2002-12-09
KR100806412B1 (ko) 2008-02-21
BR0107869A (pt) 2002-11-05
JP2003521493A (ja) 2003-07-15
AU772830B2 (en) 2004-05-06
PL356924A1 (en) 2004-07-12
EP1251829A1 (fr) 2002-10-30
ZA200205989B (en) 2003-02-03
IL150642A0 (en) 2003-02-12
CN1223340C (zh) 2005-10-19
TWI289061B (en) 2007-11-01
NZ519992A (en) 2004-04-30
WO2001054667A1 (fr) 2001-08-02

Similar Documents

Publication Publication Date Title
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it) Composizioni farmaceutiche
DK1524266T3 (da) Farmaceutisk sammensætning
NO20025450L (no) Ny farmasöytisk sammensetning
ATE303787T1 (de) Schergelzusammensetzungen
ITTO20010008A0 (it) Formulazione farmaceutica
PT1242087E (pt) Composicoes farmaceuticas
FI20011478A0 (fi) Farmaseuttinen koostumus
NO20033556L (no) Farmasöytiske formuleringer
NO20015175D0 (no) Farmasöytisk sammensetning
AR028197A1 (es) Composiciones antitranspirantes
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
EE05020B1 (et) Glburiidi ravimkoostis
EE200300589A (et) Ravimkoostised
NO20026123L (no) Farmasöytiske sammensetninger
ATE369830T1 (de) Schweisshemmende zusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
PT1239832E (pt) Composicoes farmaceuticas
FI20022128A (fi) Farmaseuttinen koostumus
NO20031095L (no) Farmasoytiske sammensetninger
DE60116858D1 (de) Zusammensetzung
FI4488U1 (fi) Farmaseuttinen koostumus
EE200200689A (et) Ravimkoostised
MXPA03001857A (es) Composicones medicinales.

Legal Events

Date Code Title Description
FB Suspension of granting procedure